Eloxx Pharmaceuticals Inc logo

Eloxx Pharmaceuticals Inc Share Price (NASDAQ: ELOX)

▲

-0.14

(-100%)

Last updated on

Bell Icon

This instrument is not available for trading on the INDmoney app on 19 Sep 2024

Check the interactive Eloxx Pharmaceuticals Inc Stock chart to analyse performance

Eloxx Pharmaceuticals Inc Key Stats

Check Eloxx Pharmaceuticals Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.14
Open
$1.0E-6
Market Capitalization
$1.9K
Today's Volume
$256.0
Revenue TTM
$0.0
EBITDA
$-19.2M
Earnings Per Share (EPS)
$-8.88
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-615.23%

Global Institutional Holdings in Eloxx Pharmaceuticals Inc

  • Name

    Holdings %

  • MENORA MIVTACHIM HOLDINGS LIMITED

    1.67%

  • Altshuler Shaham Ltd

    0.80%

  • Clal Insurance Enterprises Holdings Ltd

    0.43%

Analyst Recommendation on Eloxx Pharmaceuticals Inc Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Eloxx Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

About Eloxx Pharmaceuticals Inc

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.
Organization
Eloxx Pharmaceuticals Inc
Employees
18
CEO
Mr. Sumit Aggarwal M.B.A.
Industry
Health Technology

Important FAQs about investing in ELOX Stock from India :

What is Eloxx Pharmaceuticals Inc share price today?

Eloxx Pharmaceuticals Inc share price today is as on at the close of the market. Eloxx Pharmaceuticals Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Eloxx Pharmaceuticals Inc share?

Eloxx Pharmaceuticals Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Eloxx Pharmaceuticals Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Eloxx Pharmaceuticals Inc Stock (ELOX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Eloxx Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eloxx Pharmaceuticals Inc Shares .

What is the minimum amount required to buy Eloxx Pharmaceuticals Inc Stock (ELOX) from India?

Indian investors can start investing in Eloxx Pharmaceuticals Inc (ELOX) shares with as little as ₹93.8675 or $1 (as of March 25, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹938.68 in Eloxx Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on March 25, 2026). Learn more about fractional shares .

What are the returns that Eloxx Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Eloxx Pharmaceuticals Inc stock has given 0.0% share price returns and 29.17% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?